EligibleTrials

NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer

Recruiting · NCT05572801 · Interventional (participants receive a specific treatment) · Lead sponsor: Aarhus University Hospital

View the official record on ClinicalTrials.gov →
Colorectal cancer

Interventions studied

AMR B: HPV positive ctDNA guided imaging in follow-up

What this trial is about

This study investigates if circulating tumor DNA can improve the detection of early treatment failure or recurrence in localized squamous cell carcinoma of the anus (SCCA) after curative chemoradiotherapy thereby increasing the potential for cure. This will be done by comparing the standard follow-up program with ctDNA guided imaging follow-up. Secondly, the aim is to establish early interventions against late morbidities.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

13 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.